- Flexible Bronchoscope
- Rigid Bronchoscope
Bronchoscope Market Size was valued at USD 2.73 billion in 2022 and is poised to grow at a CAGR of 7.4% over 2023-2029. The bronchoscope is an instrument used for diagnostic and therapeutic purposes, which is inserted into the airways, usually through the nose or mouth, or occasionally through a tracheostomy, allowing the practitioner to examine the patient’s airways for abnormalities such as foreign bodies, bleeding, tumors, or inflammation. Based on the type, flexible bronchoscope is anticipated to dominate the market share over the forecast period. According to the Forum of International Respiratory Societies report 2022, approximately 200 million people are estimated to have COPD, and 262 million people are affected by asthma. The increasing respiratory disease with the rise in the geriatric population and innovations in the technology of bronchoscopy devices will act as the growth drivers for the market, however, the risk of contamination of devices, and the high overhead cost of bronchoscopy procedures may have a negative impact on the growth of the market. Emerging markets in the Asia Pacific region and increasing government reimbursement policies will be the growth opportunities for players in the market.
Fastest Growing Market
The growing burden of respiratory disease and lung cancer, hospital investment in bronchoscopy facilities, and technological advancements will support the growth of the bronchoscope market. Moreover, the application of a bronchoscope for examining COVID-19 and associated diseases had a positive impact on the growth of the market. For instance, in April 2021, the European Respiratory Society allowed the use of bronchoscopes for the removal of mucus plugs and intrabronchial clots and the resolution of atelectasis, thereby improving mechanical ventilation in patients. Thus, the increased awareness, research, and development for respiratory diseases will lead to the growth of the market in the forecast period.
The bronchoscope market was valued at USD 2.73 billion in 2022 and is expected to grow at a 7.4% CAGR over the forecast period 2023 – 2029.
Emerging markets in the Asia Pacific region, and increasing government reimbursement policies are the key opportunities for the Bronchoscope market.
The increasing respiratory disease with the rise in the geriatric population and innovations in the technology of bronchoscopy devices are the growth drivers in the Bronchoscope market.
Teleflex Inc., Karl Storz GmbH, Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Pentax Medical, Novatech SA, and Lymol Medical are a few companies operating in the Bronchoscope market.